Lasofoxifene
is a third-generation, non-steroidal careful estrogen receptor modulator (SERM).
It selectively binds to animal ERα with an IC50 amount of 1.5 nM and inhibits
cartilage accident in ovariectomized rats. In analytic studies of
postmenopausal osteoporosis, 0.5 mg/day lasofoxifene was associated with
bargain risks of nonvertebral and vertebral fractures, ER-positive breast
cancer, coronary affection disease, and achievement but an added accident of
venous thromboembolic events. Lasofoxifene has aswell been apparent to act as
an changed agonist at the CB2 cannabinoid receptor, advertence its abeyant to
be repurposed as a ameliorative for break wherein CB2 is a target.
Lasofoxifene
is a naphthalene acquired and a desmethyl dihydro alternation of nafoxidine.
